Src inhibits adriamycin-induced senescence and G2 checkpoint arrest by blocking the induction of p21waf1.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Research

• Publication date

  2005-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-05-0461PMID 16204065
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Implication of BRG1 and cdk9 in the STAT3-mediated activation of the p21waf1 gene

  2004cited by this paper
• Hallmarks of senescence in carcinogenesis and cancer therapy

  2004cited by this paper
• Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy

  2004cited by this paper
• Opposite Regulation of Myc and p21 waf1 Transcription by STAT3 Proteins*

  2003cited by this paper
• Apoptosis Genes and Resistance to Cancer Therapy: What Does the Experimental and Clinical Data Tell Us?

  2003cited by this paper
• Chemotherapy response and resistance.

  2003cited by this paper
• The role of p53 in determining sensitivity to radiotherapy

  2003cited by this paper
• G2 and spindle assembly checkpoint adaptation, and tetraploidy arrest: implications for intrinsic and chemically induced genomic instability.

  2003cited by this paper
• Identification of Promoter Elements Responsible for Transcriptional Inhibition of Polo-like Kinase 1 and Topoisomerase IIα Genes by p21WAF1/CIP1/ SDI1

  2002cited by this paper
• E7 Abolishes Raf-Induced Arrest via Mislocalization of p21Cip1

  2002cited by this paper
• Functional Interaction of STAT3 Transcription Factor with the Coactivator NcoA/SRC1a*

  2002cited by this paper
• 5' CpG island hypermethylation is associated with transcriptional silencing of the p21(CIP1/WAF1/SDI1) gene and confers poor prognosis in acute lymphoblastic leukemia.

  2002cited by this paper
• Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.

  2002cited by this paper
• Apoptosis A Link between Cancer Genetics and Chemotherapy

  2002cited by this paper
• Negative regulation of the mammalian UV response by Myc through association with Miz-1.

  2002cited by this paper
• Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3

  2001cited by this paper
• Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis

  2001influential reference
• Cyclin D1 Represses STAT3 Activation through a Cdk4-independent Mechanism*

  2001cited by this paper
• Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells

  2001cited by this paper
• Neither p21WAF1 nor 14-3-3sigma prevents G2 progression to mitotic catastrophe in human colon carcinoma cells after DNA damage, but p21WAF1 induces stable G1 arrest in resulting tetraploid cells.

  2001cited by this paper
• BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance.

  2001cited by this paper
• Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases.

  2000cited by this paper
• Regulation of both apoptosis and cell survival by the v-Src oncoprotein

  2000cited by this paper
• Functional Interaction of STAT3 Transcription Factor with the Cell Cycle Inhibitor p21 WAF1/CIP1/SDI1 *

  2000cited by this paper
• The p21(WAF1/CIP1) promoter is methylated in Rat-1 cells: stable restoration of p53-dependent p21(WAF1/CIP1) expression after transfection of a genomic clone containing the p21(WAF1/CIP1) gene.

  2000cited by this paper
• The p21WAF1/CIP1 Promoter Is Methylated in Rat-1 Cells: Stable Restoration of p53-Dependent p21WAF1/CIP1 Expression after Transfection of a Genomic Clone Containing the p21WAF1/CIP1 Gene

  2000cited by this paper
• Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma

  1999cited by this paper
• Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs

  1999cited by this paper
• A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents.

  1999cited by this paper
• Stat3 Activation by Src Induces Specific Gene Regulation and Is Required for Cell Transformation

  1998cited by this paper
• Stat3 Activation Is Required for Cellular Transformation by v-src

  1998influential reference
• The Myc negative autoregulation mechanism requires Myc-Max association and involves the c-myc P2 minimal promoter

  1997cited by this paper
• Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21

  1996cited by this paper
• DNA damage and p53-mediated cell cycle arrest: a reevaluation.

  1996cited by this paper
• Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein.

  1995cited by this paper
• Synergistic effect of the v-myc oncogene with H-ras on radioresistance.

  1990cited by this paper

• Etiology of polyploid giant cancer cells: a new frontier in cancer biology

  2026cites this paper
• Polyploidy as an outcome of anticancer therapies and a contributing cause of their lack of efficacy

  2024cites this paper
• Discovery of two biotin-PEG4‑diarylidenyl piperidone prodrugs as potent antitumor agents with good efficacy, limited toxicity, and low resistance.

  2022cites this paper
• Molecular Mechanisms of Senescence and Implications for the Treatment of Myeloid Malignancies

  2021cites this paper
• Polyploidy formation in cancer cells: how a Trojan horse is born.

  2021cites this paper
• Anticancer Imidazoacridinone C-1311 is Effective in Androgen-Dependent and Androgen-Independent Prostate Cancer Cells

  2020cites this paper
• Chemotherapy-induced senescence, an adaptive mechanism driving resistance and tumor heterogeneity

  2019cites this paper
• Regulation of senescence escape by TSP1 and CD47 following chemotherapy treatment

  2019cites this paper
• Doxorubicin and liposomal doxorubicin induce senescence by enhancing nuclear factor kappa B and mitochondrial membrane potential.

  2019cites this paper
• CD59 is a potential biomarker of esophageal squamous cell carcinoma radioresistance by affecting DNA repair

  2018cites this paper
• Regulation of senescence escape by the cdk4–EZH2–AP2M1 pathway in response to chemotherapy

  2018cites this paper
• Actin-binding doliculide causes premature senescence in p53 wild type cells.

  2016cites this paper
• Morphological and Functional Characteristic of Senescent Cancer Cells.

  2016cites this paper
• Cisplatin-selected resistance is associated with increased motility and stem-like properties via activation of STAT3/Snail axis in atypical teratoid/rhabdoid tumor cells

  2015cites this paper
• Effects of aqueous extract of Salvia officinalis on some parameters of sperms and histopathological changes in testes of rats treated with Doxorubicin

  2014cites this paper
• v-Src inhibits the interaction between Rad17 and Rad9 and induces replication fork collapse.

  2014cites this paper
• The role of STAT3 signaling in mediating tumor resistance to cancer therapy.

  2014cites this paper
• Circulating miRNAs as new activators of the JAK-STAT3 pathway

  2013cites this paper
• Polyploidy road to therapy‐induced cellular senescence and escape

  2013cites this paper
• A new p53 target gene, RKIP, is essential for DNA damage-induced cellular senescence and suppression of ERK activation.

  2013cites this paper
• Doxorubicin‐induced death in tumour cells and cardiomyocytes: is autophagy the key to improving future clinical outcomes?

  2013cites this paper
• Wig1 prevents cellular senescence by regulating p21 mRNA decay through control of RISC recruitment

  2012cites this paper
• Inhibition of Doxorubicin-Induced Senescence by PPARδ Activation Agonists in Cardiac Muscle Cells: Cooperation between PPARδ and Bcl6

  2012cites this paper
• Tumour suppressor genes in chemotherapeutic drug response

  2012cites this paper
• Novel patented SRC kinase inhibitor.

  2012cites this paper
• Clinical significance of Src expression and activity in human neoplasia.

  2012cites this paper
• Cyclopentenyl Cytosine Induces Senescence in Breast Cancer Cells through the Nucleolar Stress Response and Activation of p53

  2011cites this paper
• Escape from p21-mediated Oncogene-induced Senescence Leads to Cell Dedifferentiation and Dependence on Anti-apoptotic Bcl-xL and MCL1 Proteins*

  2011cites this paper
• Dose- and time-dependent effects of doxorubicin on cytotoxicity, cell cycle and apoptotic cell death in human colon cancer cells.

  2010cites this paper
• Regulation of the Aurora-A gene following topoisomerase I inhibition: implication of the Myc transcription Factor

  2010cites this paper
• In vivo targeting of the growth hormone receptor (GHR) Box1 sequence demonstrates that the GHR does not signal exclusively through JAK2.

  2010cites this paper
• Estrogen Prevents Senescence through Induction of WRN, Werner Syndrome Protein

  2010cites this paper
• The cdk5 Kinase Regulates the STAT3 Transcription Factor to Prevent DNA Damage upon Topoisomerase I Inhibition*

  2010cites this paper
• Oridonin induces apoptosis and senescence in colorectal cancer cells by increasing histone hyperacetylation and regulation of p16, p21, p27 and c-myc

  2010cites this paper
• Weak p53 permits senescence during cell cycle arrest

  2010cites this paper
• 1,25‐dihydroxyvitamin D3 and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cells

  2010cites this paper
• p38 MAPK and JNK Antagonistically Control Senescence and Cytoplasmic p16INK4A Expression in Doxorubicin-Treated Endothelial Progenitor Cells

  2010cites this paper
• Sensitization of cervix cancer cells to Adriamycin by Pentoxifylline induces an increase in apoptosis and decrease senescence

  2010cites this paper
• Tyrosine Kinase Inhibitors in Triple Negative Breast Cancer

  2010cites this paper
• CIP4 and Src in Promoting the Migration and Invasion of Breast Cancers

  2010cites this paper
• Oncogène RAS et Cancer Colorectal : Étude de la Réponse au Stress Oncogénique et de l'Échappement à la Sénescence

  2010cites this paper
• Prevention of premature senescence requires JNK regulation of Bcl-2 and reactive oxygen species

  2010cites this paper
• Induction of senescence with doxorubicin leads to increased genomic instability of HCT116 cells.

  2009cites this paper
• Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2.

  2009cites this paper
• Replication checkpoint control by a PTK/STAT3/Cyclin D1 axis

  2009cites this paper
• Apoptosis, autophagy, accelerated senescence and reactive oxygen in the response of human breast tumor cells to adriamycin.

  2009cites this paper
• Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells

  2009cites this paper
• Oncogene activation in melanocytes links reactive oxygen to multinucleated phenotype and senescence

  2008cites this paper
• Heterogeneous in vitro effects of doxorubicin on gene expression in primary human liposarcoma cultures

  2008cites this paper
• The EGFR-STAT3 oncogenic pathway up-regulates the Eme1 endonuclease to reduce DNA damage after topoisomerase I inhibition.

  2008cites this paper
• Antiproliferative effect of sulindac in colonic neoplasia prevention: role of COOH-terminal Src kinase

  2008cites this paper
• Physiology of the prion protein.

  2008cites this paper
• Heterogeneous in vitro effects of doxorubicin on gene expression in primary human liposarcoma cultures

  2008cites this paper
• Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity

  2008cites this paper
• Cell cycle-dependent regulation of SFK, JAK1 and STAT3 signaling by the protein tyrosine phosphatase TCPTP

  2008cites this paper
• Recent progress of SRC family kinase inhibitors as anticancer agents.

  2008cites this paper
• The c-myc promoter: still MysterY and challenge.

  2008cites this paper
• Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation.

  2008cites this paper
• Inhibitory effect of schisandrin B on gastric cancer cells in vitro.

  2007cites this paper
• Novel JAK 2 Inhibitor , Increases Chemotherapy Sensitivity in Human Ovarian Cancer Cells

  2007influential citation
• The STAT3 oncogene as a predictive marker of drug resistance.

  2007cites this paper
• SD-1008 a Novel JAK2 Inhibitor, Increases Chemotherapy Sensitivity in Human Ovarian Cancer Cells

  2007influential citation
• 8-Benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic Acid (SD-1008), a Novel Janus Kinase 2 Inhibitor, Increases Chemotherapy Sensitivity in Human Ovarian Cancer Cells

  2007influential citation
• Src kinase inhibitors for the treatment of sarcomas: Cellular and molecular mechanisms of action

  2007cites this paper
• Sequential induction of mitotic catastrophe followed by apoptosis in human leukemia MOLT4 cells by imidazoacridinone C-1311

  2007cites this paper
• Attenuation of DNA damage checkpoint by PBK, a novel mitotic kinase, involves protein-protein interaction with tumor suppressor p53.

  2007cites this paper
• The Interactive Transcript Abundance Index [c-myc*p73á]/[p21*Bcl-2] Correlates With Spontaneous Apoptosis and Response to CPT-11: Implications for Predicting Chemoresistance and Cytotoxicity to DNA Damaging Agents

  2006cites this paper
• Rôle des facteurs de transcription stat3 dans la réponse aux inhibiteurs de topoisomerase : Implication dans la résistance aux traitements de chimiothérapie

  2006cites this paper